Narducci Maria Lucia, Niccoli Giampaolo, Flore Francesco, Perna Francesco, Bencardino Gianluigi, Montone Rocco Antonio, Pelargonio Gemma, Crea Filippo
Dipartimento di Scienze Cardiovascolari, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
Dipartimento di Medicina e Chirurgia, Università di Parma, 43125 Parma, Italy.
J Clin Med. 2022 Dec 2;11(23):7181. doi: 10.3390/jcm11237181.
Chronic coronary total occlusions (CTO) are considered an emerging predictor of ventricular arrhythmias (VAs), but currently there are few data on arrhythmic outcomes in patients affected by CTO undergoing radiofrequency catheter ablation of VAs. This study sought to evaluate the impact of unrevascularized CTO on the recurrence of VAs after catheter ablation. This was a single-center retrospective study enrolling 120 patients between 2015 and 2020. All patients were admitted for ventricular tachycardia (VT) or high premature ventricular contractions burden (>25% detected by Holter ECG), without evidence of acute coronary syndrome; they underwent coronary angiography, electrophysiology (EP) study, and three-dimensional electroanatomic mapping (3D-EAM) followed by VAs ablation. Twenty-eight patients (23%) of 120 patients showed CTO at coronary angiography. At baseline, the CTO group presented with higher prevalence of hypertension, chronic renal disease, systolic ventricular dysfunction, secondary prevention ICD implantation, and higher rate of LAVA by 3D-EAM compared with the non-CTO group. At a median follow-up of 15 months (range 1−96 months) after catheter ablation, the only independent predictor of VAs recurrence was the presence of moderate to severe left ventricular (LV) dysfunction. Therefore, the presence of CTO does not predict VAs recurrence after catheter ablation, which is instead predicted by LV dysfunction.
慢性冠状动脉完全闭塞(CTO)被认为是室性心律失常(VA)的一种新的预测指标,但目前关于接受VA射频导管消融术的CTO患者心律失常结局的数据较少。本研究旨在评估未血运重建的CTO对导管消融术后VA复发的影响。这是一项单中心回顾性研究,纳入了2015年至2020年间的120例患者。所有患者均因室性心动过速(VT)或高室性早搏负荷(动态心电图检测>25%)入院,无急性冠状动脉综合征证据;他们接受了冠状动脉造影、电生理(EP)检查和三维电解剖标测(3D-EAM),随后进行VA消融。120例患者中有28例(23%)在冠状动脉造影时显示CTO。基线时,与非CTO组相比,CTO组高血压、慢性肾病、收缩期心室功能障碍、二级预防ICD植入的患病率更高,3D-EAM显示的LAVA发生率更高。在导管消融术后的中位随访15个月(范围1 - 96个月)时,VA复发的唯一独立预测因素是中度至重度左心室(LV)功能障碍。因此,CTO的存在并不能预测导管消融术后VA的复发,相反,LV功能障碍可预测VA复发。